Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
maprotiline
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Generic mfg.
Drug class:
Norepinephrine reuptake inhibitor, Noradrenaline uptake inhibitor, α2 adrenergic receptor antagonist
Related drugs:
‹
amitriptyline (1)
imipramine (1)
iobenguane I 131 (0)
clonidine MBT (0)
amitriptyline (1)
imipramine (1)
iobenguane I 131 (0)
clonidine MBT (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
PD-L1 expression
Melanoma
PD-L1 expression
Melanoma
maprotiline
Sensitive: C3 – Early Trials
maprotiline
Sensitive
:
C3
maprotiline
Sensitive: C3 – Early Trials
maprotiline
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.